The live patient guidance platform uses artificial intelligence to find gaps in care

Genome Standardization, Mark Cuban file The company announced a new partnership this week that the company says can help personalize and personalize patient care insights based on their medical records and identify potential gaps in care. The company said Monday that its direct-to-consumer platform uses artificial intelligence to analyze the medical care patients may have received and alert them to missing tests or treatment options.

This technology, already used in the treatment of amyotrophic lateral sclerosis, some cancers and other rare diseases, and enabled by healthcare interoperability requirements on healthcare providers, presents a new direction in patient engagement: by offering a mechanism for patients to share their medical records and then analyze the treatment data. To report it. Likely to miss tests and treatments, Unite partners take an active role in care conversations.

Why does it matter?

The California-based health analytics and personal engagement platform said in a statement that its newest pharma partner will integrate AI-powered clinical listening technology directly into its patient engagement efforts.

Patients must agree to let Unite’s platform access and consolidate their medical data from multiple providers, said Theo Ahadum, Unite’s chief commercial officer. Healthcare IT News Wednesday.

He said 90% of patients in the United States will be able to find their electronic health records accessible through the company’s platform. Unite can access patient records from more than 12,000 health systems, thanks to the 21st Century Cures Act and its mandate that health care providers provide patients with access to their records.

The platform can import more than 1,500+ electronic health record data elements, according to the Unite website.

The primary use case for patients is to share their consolidated medical records with a new provider, which is much faster than requesting them from multiple providers who may all fax medical record data, Ahadum explained.

However, the DTP platform also analyzes patients’ medical data and doctors’ feedback to provide personalized insights through generative AI that can support their treatment journeys. It is being used through existing partnerships to analyze care gaps related to rare diseases, such as amyotrophic lateral sclerosis, muscular dystrophy, and breast and lung cancer, Ahadum said.

Unite said on its website that it leverages world-class artificial intelligence systems to understand patient care and make recommendations. It is trained on accepted standards — such as FDA-approved medical guidelines and treatment lists — to understand what “should happen” in a patient’s care, according to Ahadum.

As a patient, “you might want to ask questions, like: ‘Am I getting the best possible care for my condition?’ “And this is where it gets more interesting,” he said.

For example, a patient diagnosed with breast cancer should undergo biomarker genetic panel testing, based on National Comprehensive Cancer Network best practice guidelines.

“If for some reason it is not done, we can point that out,” Ahadomi said.

It should be noted that there is no direct purchase of therapeutic drugs.

But by ingesting electronic health record data and analyzing patients’ risk factors, then using genetic AI to engage patients, Unite and its partners say they can remove friction from the treatment journey — and potentially improve patient outcomes.

“Of course, we don’t prescribe or provide care. But we give you information that you can then take back to your doctor to have a conversation.”

He said a patient should talk with their health care provider “to obtain treatment that the health care provider feels is appropriate.”

Unite provides patients with specific information based on its partnerships. The AI ​​can indicate that patients with psoriasis who take topicals or creams may need systemic treatments, and can advise them on available FDA-approved oral or biologic medications.

“Then the patient has to take that letter to their doctor to have that conversation,” Ahadum said.

He noted that clinical listening can support all chronic conditions and cancer.

“It is particularly useful in cases where a patient has multidisciplinary care teams or may be receiving care from many different institutions.”

He added that while psoriasis care is the platform’s first test case outside of rare diseases and cancer, Unite plans to expand deployments to cardiovascular disease, other cancers and more, over the next 12 months.

The biggest trend

“Clinical listening” through direct relationship with patients can enhance access to treatment at pivotal moments in their care journeys.

However, while DTP technology could enable patients to advocate for the best possible treatment options, members of Congress and others are concerned about potential conflicts of interest for drug companies offering direct sales.

In August, Pfizer pledged to lower specialty drug costs and simplify access to routine health care with partners like Instacart and Zocdoc on an easy-to-use web-based platform aimed directly at consumers.

The DTP space, called PfizerForAll, allows patients to use their existing health insurance and pharmacy programs to talk to a doctor on UpScript or book an appointment on Zocdoc and get support with prior drug authorizations.

Forbes He pointed to the emerging trend of pharmaceutical companies Selling directly to consumers Such as the possibility of circumventing doctors’ direct knowledge of the patient’s medical history and accompanying diseases.

lawmakers asked recently Pharmaceutical companies are questioning their exploitation of virtual care.

In a letter to CEOs of Pfizer and Eli Lilly, four senators, led by U.S. Senate Majority Whip Dick Durbin, D-Ill., said they were also concerned about creating the potential for inappropriate prescribing that could increase spending on federal health care programs. Noting that the Anti-Kickback Statute prohibits the intentional payment of wages to induce patients to refer Medicaid-covered medical care, services, or goods.

registered

“We created Unite to help close gaps in care and improve the healthcare system as a whole,” Tanner Dagdelen, founder and CEO of Unite, said in a statement.

“We are excited to expand its use into psoriasis, a disease with significant treatment challenges and complex patient journeys, through this partnership.”

Andrea Fox is a senior editor at Healthcare IT News.
Email: afox@himss.org
Healthcare IT News is a HIMSS media publication.